Peer Review History
| Original SubmissionJune 23, 2020 |
|---|
|
PONE-D-20-19358 Voice rest following vocal fold injury: The molecular perspective PLOS ONE Dear Dr. Hortobagyi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 27 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Marie Jetté Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes Reviewer #3: No Reviewer #4: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: No Reviewer #3: No Reviewer #4: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: No Reviewer #3: Yes Reviewer #4: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The paper used a custom bioreactor to simulate vibratory stresses as of human phonation. The goal of this study was to evaluate short-term effects of vibration on human vocal fold fibroblasts primed with IL1-beta and TGF-beta1. The overall motivation of the study was clinically relevant. However, major concerns especially on the methodology and results sections will need to be addressed. Specific comments are as below. (1) Introduction: The literature review is insufficient. A more thorough review on existing vocal fold bioreactors (in vitro work) such as Barlett et al., 2019, Kim et al., 2016 and Latifi et al., 2016 as well as the perspective of voice rest after phonosurgery (in vivo work) such as Dhaliwal et al., 2019, Whitling et al., 2018 and Rinkanen et al., 2019 should be reviewed descriptively. (2) Methodology: In general, more details about the protocols are expected for experimental replication. Please include catalogue numbers for all biochemical/ molecular assays, e.g., LDH Assay, lysis reagent etc. (3) Cell culture and treatment: Please describe which cell passages were used. For the BioFlex culture plates, were the cells seeded on a plastic membrane? If so, what was the pore size and other structural/ membrane properties of the member? All these factors will affect cell adhesion, diffusion, mobility and proliferation. Also, please provide more details what exactly "inert macromolecules" were used and why crowded conditions were constituted and required. Would the presence of the macromolecules confound the results? Explain why IL-1beta and TGF-beta1 and at such dose/ exposure were used to prime the cells. Any validation tests were done to ensure that the cytokine priming worked. If so, please present the results. (4) Mechanical stimulation: More details about the oscillation such as vibratory amplitude are needed to provide a better view of the bioreactor functionality. (5) LDH assay: This paragraph needs more editing as some punctuation marks or grammatical errors were spot. Also, what's the volume of supernatant collected for the assay? (6) RNA isolation: Any estimation of the cell retrieval efficiency for the RT-qPCR? If the cells were strongly attached on the membrane, it would not be easy to retrieve all cells and the harsh reagents may change the phenotype of the cells. The selection of gene markers should be justified. (7) Western blot analysis: For the primary antibodies, were they mono- or polyclonal? The selection of intracellular protein markers should be justified. (8) Luminex: Please provide more details about the procedures and the protocol, e.g., standards, blank controls etc. The selection of the protein markers should be justified. Usually when multiplex assay was run, a validation step of selected markers are needed. Please explain if any validation was done with the Luminex results. If not, why not? (9) ELISA: Please provide more details about the procedures and the protocol, e.g., blank controls, catalogue number etc. The selection of the single HA marker should be justified. (10) Statistics: Please make it clear which variables were treated as "between-subject" independent variables and which comparisons were made in the design. (11) Results: Please report all results include those of LDH and the TIMP1. Also, the presentation of the results were mixed with PCR, mRNA, Luminex and ELISA. As the choice of markers lacks justification in the methodology, it made the results herein very difficult to follow and comprehend. A reorganization of this section in terms of writing and figures (Figure 2-5) is strongly needed. Please include asterisk for significant values. For the decimal numbers above the bars (Figure 2-5), what did these numbers represent? Were they p-value from ANOVA or post-hoc pairwise comparison? (12) Results: Figure 3. For Col1A1, the pattern of changes for "+ cytokine" between static and dynamic conditions are different for (d) and (e). Why so? Such results should be in sort of agreement. (13) Discussion: In general, please denote clearly which figure that the results were referred to in the main text. Also, some claims were not supported by the results. For example, Line 321-324 claimed that their results showed up-regulated ECM- and inflammation-related genes and proteins. However, Figure 5 showed the downregulation but not the upregulation for ACTA2, TGFbeta 1, IL-11 and alpha-SMA under the "+ cytokine/ dynamic" condition, compared to the "+cytokine/ static" condition. (14) Please include a more thorough discussion around the biological/ physiological functions of IL-11 on fibroblasts and the synergistic interactions of IL-11 with other cytokines. (15) Please discuss what the limitations and future direction of this study. Reviewer #2: The main finding in this paper is that vibration of hVFFs results in reduced expression of pro-inflammatory cytokines and smooth muscle actin while in an induced inflammatory state.The ECM component HA which is necessary for reduction of fibrosis is not influenced by vibration. The introduction is brief and fails to acknowledge clinical studies addressing vocal rest/use post-surgery, findings which provide necessary context to this manuscript. The methodology is well designed and reflects an appropriate number of replicates. The results are of interest to the field and align with early ambulatory recovery guidelines in other disciplines. The discussion section fails to address any limitations of the study and is oversimplified such that some statements are partially incorrect. If the findings of this study translate to human voice they may have a significant impact on post-surgery guidance for voice use following phonosurgery. The manuscript would benefit from external copy-editing as there are many instances where the meaning is unclear, or wording is inappropriate. No supplementary materials were available in the reviewer’s download so it is unclear if all the data is freely available. Specific comments: Title: gives the impression this is a review or conducted in humans, should reflect study more accurately. Abstract: Line 18: word choice - Reword to reflect that biopsies for molecular biology studies are unethical, as biopsies are possible. Line 19: word choice - As the model had been established prior (cell line Thiebault, biomechanical reactor in a previous publication) reword to reflect utilization of a previously developed in vitro phonomimetic biomechanical model. Line 24: word choice - Wording ambiguous as to whether the mechanical stimulus or cytokine stimulus is applied for 4 hours. Introduction: This section fails to address the role of voice therapy in the treatment of vocal fold lesions – for most lesions voice therapy is recommended in combination with surgery, and in some cases alone. Omission of voice therapy weakens this section substantially. Line 41: word choice - sentence meaning is unclear. Reword to reflect damage caused surgically, or mechanically by phonotrauma lead to an upregulation of inflammatory cytokines. Line 44: word choice - use of “the worst-case” unnecessary and changes sentence meaning. Line 46/47: word choice – reword to reflect that these findings may influence clinical practice guidelines. Line 57: The statement, “barely any sound evidence,” is inappropriate. There are several peer reviewed articles addressing voice rest/use following phonomicrosurgery. See Bercirovic et al. 2019, Whitling et al. 2018, Kiagadaki et al. 2014, and Wang and Huang 1994. The findings of these studies lack consensus and serve to strengthen the authors arguments. Line 59: word choice – the healing process is influenced/impacted by these factors, “trigger” is not correct in this usage. Line 65: word choice – consider necessary or essential as opposed to mandatory, changes sentence meaning. Line 66/67: ECM production changes are inadequately referenced. Line 68: While there is not much evidence, Zhang et al. 2015 describe the impact of cyclic tensile strength on hVFFs in the presence of cigarette smoke and should be included here. Methods: Line 85: word choice – remove “Therefore.” Line 94: word choice – sentence does not make sense. Reword to reflect that inclusion of inert macromolecules enhances ECM production such that it is easier for researchers to evaluate them in culture. Line 99: word choice – “foreseen” used incorrectly, consider stratified/randomized/ or assigned to throughout the manuscript Line 119: word choice – reads awkwardly. Consider rewording “orientating on the publication of…” to, “as described by.” Line 119: double period at end of sentence. Line 120: word choice – “foreseen” incorrectly used Line 139/140: How was the RNA quality established? No mention of RIN or the use of a denaturing agarose gel. This data is essential to ensuring the RNA meets quality standards for qPCR. Line 144: Please include more details for the reaction (number of cycles, temperature, nucleic acid dye, etc.) Looking at the paper referenced in this section this too lacks details about the qPCR methods. Line 152: double period at end of the sentence. Statistical Analysis: General: Include effect sizes in the manuscript as these may demonstrate clinical implications where non-significant “trends” are observed. Consider Gaeta and Brydges 2020 JSLHR article when reporting effect size. Results: General: Include p values and effect sizes in the text describing the results. General: Include p values and effect sizes in the Figure legends. General: This section would benefit from external copy-editing. A number of sentences are unclear in their meaning, and there is a repeated use of some phrases which read unclearly or strangely, e.g. failed statistical significance, not altered by. Line 213: word choice – change “under” to with. Line 214: word choice – consider rewording to, “Gene expression results were consistent with significantly elevated transcript levels of HAS1 and HAS3.” Line 231: word choice – reword “failed statistical significance” to something like “did not meet statistical significance” throughout. Line 246: word choice – insert, “and was” before, “not altered by additional…” Line 262: Figure legend for Fig 4 is incomplete. Line 265 – 267: word choice – sentence meaning is unclear. Do the authors mean that non-significant upregulation was observed with cytokine treatment alone? Line 274: word choice – reword, “under” to, “in the.” Discussion: General: There is no discussion of limitations within the study. These include: 1) The use of SYBR for qPCR. SYBR dye binds to double stranded DNA in a non-specific manner, thus does not confirm that the correct transcript has been replicated. Use of a Dual-labeled Primer (e.g. TaqMan) is more specific and reproducible. 2) Immortalized cell lines lack a bloody supply, and thus inflammatory observations are made outside of a normal physiologic system and may not be translatable to in vivo. 3) Immortalized cell lines have inherent property changes from primary cells or in vivo cells and may behave differently. 4) In vitro biomechanical manipulation is an approximation of voice and may not apply identical shearing and stress forces as observed in physiologic voice Line 292: The role of inflammation is grossly understated. Inflammation is also required for homeostasis/adaptation to stress/promotion of healing/recruitment of host immune response, etc. Line 319: Italicize in vivo. Line 326: Statement is incorrect. Rousseau model is a controlled vibratory phonation model using electrical stimulation to elicit vocalization. See Kimball et al. 2019 for information on stimulation and vibratory patterns in this model. Line 340: spelling incorrect – glycosaminoglycan Line 346: word choice – use of, “could” is ambiguous, consider, “demonstrated an increase…” Line 352: word choice – use of, “could” is ambiguous, consider, “did not…” Line 354: Please change ex vivo to in vitro. Ex vivo implies minimal changes to the tissue upon removing it from the body. Line 387: italicize in vivo Figures: General: Consider removing the p values from the figures and use Asterix to denote the level of significance. The p values make the graphs seem over complicated. Reviewer #3: This is an interesting paper describing application of a sophisticated bioreactor for studying inflammatory signaling in VFFs in concert with a vibratory stimulus. The bioreactor technology has previously been published by the group. This work is certainly a useful contribution to the literature, and I offer the following comments and suggestions: 1. Is the vibratory dose delivered to the 6 well plate uniform across all wells, or does it vary based on the position of the well? If there is well-to-well variation, how significant is this and how was it managed? 2. MMC was used in all conditions to enhance biological responsiveness and more closely simulate a fibrosis situation, however this is just mentioned briefly in the Method section. It would be very helpful to show the effect of MMC on the cytokine and vibration responses here – ideally with a non-MMC experimental condition or, if not practical, by describing the results in light of this groups’ prior publication that showed the influence of MMC alone on VFF biology in vitro. This really should have more emphasis, especially when the authors interpret and compare their results to those of others who did not use MMC in their experiments. 3. I appreciate the care given to Tukey adjustment and parametric versus non-parametric statistical test selection, but wonder if these data would be best handled by a 2-way ANOVA in which cytokine treatment and vibration treatment are handled as independent variables, with their interaction effect included. The interaction between these experimental stimuli may be important here. Also, with no word or page limits in this online journal, I please report the results of the F and KW tests (not just the significant pairwise comparisons), as well as the nonsignificant LDH data. These can easily be placed in a supplementary materials section. 4. Finally, I suggest more careful and conservative description of the clinical and wound healing issues that motivate the work and are described in the Introduction and Discussion. For example: a. Early inflammation is not just for avoiding infection (start of Discussion). There is much more complex biology involved. b. I disagree that there is a lack of clinical recommendations for voice rest (Abstract); rather there is a lack of UNIFORM recommendations. c. The comparison of VF vibration with orthopedic mobilization after injury or surgery is a more complex and nuanced comparison than is suggested (Introduction). These are quite different mechanical situations and I suggest describing in more detail. d. I suggest citations to support “size of the VF lesion, smoking status, sex, age etc” (Introduction). e. Paragraph 2 in the Discussion might fit better in the Introduction. f. I think that “in vivo” (line 387, Conclusion) was intended to be “in vitro”. Reviewer #4: The purpose of the current study was to explore the effects of vibration on hVFF in an inflammatory and normal state. I very much like the premise of this study as it provides an important avenue to discuss biological outcomes associated with mechanical stimulation following inflammation. However, I have concerns regarding manuscript overall clarity, methodological decisions, and the conclusion. Specific comments are listed by section. Title / Abstract • I would consider changing the title of the manuscript. First, it sounds like the paper is a Review as opposed to an experimental study. Also, it is truly not reflective of what was done in the study. Vocal folds were not injured. VFF were treated with an inflammatory challenge. • The Introduction statement of the abstract is not clear. The important role of voice rest is introduced, but then stated that the authors seek to evaluate the effect of vibration on VFF. Introduction • Not all readers will be familiar with voice rest recommendations following phonosurgery. The Introduction would benefit from a brief overview (1-2 sentences) of typical voice rest recommendations. This would provide some context for the reader. • The authors begin the Introduction discussing upregulation of inflammatory cytokines following phonotrauma, but not mention of the inflammatory cascade following phonosurgery. This should be mentioned as I think the authors are making of case to study the role of voice rest following phonotrauma and/or vocal fold surgery. • The Introduction needs further information (1-2 sentences) regarding the important role of VFF in vocal fold physiology. • In general, it is unclear that the authors are trying to mimic inflammation following phonotrauma or phonosurgery and the subsequent role of vibration versus rest. • The objective of the study is listed as studying the cellular responses of hVFF following a profibrotic and inflammatory stimulus under static and dynamic conditions. I have several concerns with this statement. First, cellular responses is extremely broad and can encompass a huge range of factors. I would recommend expanding upon this. Furthermore, the authors state in the title that they are seeking to study the molecular, not cellular perspective. It is unclear that static and dynamic is supposed to related to vocal fold rest and vibration, respectively. Finally, while inflammation if briefly introduced, what is the importance of a pro-fibrotic stimuli? Methods • Please provide justification regarding the choice to serum starve the VFF. Serum starvation has been shown to cause cells to undergo apoptosis and increase cell susceptibility to inflammatory stimuli. • The term pro-fibrotic and inflammatory culture conditions is utilized. While the use of the inflammatory makes sense, pro-fibrotic is confusing. Please provide justification / citations regarding the pro-fibrotic effect of these cytokines. • It is stated that these cytokines were capable of maintaining a consistent inflammatory reaction for at least 72 hours. How was this measured / verified? • I realize that the cells were only vibrated for four hours, but in the initial section regarding cell culture and treatment it reads like the cells were vibrated for 72 hours. • In Mechanical Stimulation, I know that a citation is provided, but it would still benefit from 1-2 sentences justifying how vibration parameters and time relate to human voice production. • It is unclear to me how the cell viability assay was conducted. The authors state to evaluate maximum LDH activity, cells were seeded in parallel….. Were the cells seeded after mechanical stimulation for the purpose of this assay? How would that potentially affect the viability results? Please clarify. • In addition, the authors state that LDH activity of the samples was expressed as percentage of the maximal LDH activity. However, this data is never presented. • There is no justification in the Introduction or Methods regarding the choice to evaluate various classes of genes and proteins. It is not until the Discussion that the importance of looking at these factors is even mentioned, albeit relatively briefly. This should really come earlier in the manuscript and be expanded. Results • Although NS, I feel the manuscript would benefit from inclusion of the viability data. • Subheading including ECM, angiogenic factors, fibrogenic markers are first introduced in the Results section. These are important classes of genes and proteins and it is strange to see these subheadings for the first time in the Results section. • I find the results very difficult to follow. Specifically, the most important findings (e.g. IL11) are difficult to realize, because so many genes are discussed typically individually. I believe there some redundancies were the same genes demonstrate the same findings in terms of significance related to inflammatory condition and vibration. I wonder if there is a way for the authors to condense / re-organize. • The authors frequently use the terms trending towards significance, near significance etc. I would suggest being more judicious with the use of these terms. These are not significant findings. Any interesting trends the authors may wish to save for the Discussion. Discussion • The overall setup for the manuscript is much clearer in the first paragraph of the Discussion than any other part of the manuscript. • The authors indicate that different inflammatory and pro-fibrotic stimuli were investigated based on previous publications of in vitro inflammation. Were these studies with VFF or other cell types? Furthermore, on page 17 the authors discuss inflammatory cytokines following vocal fold injury in vivo. This Discussion should be moved up and used to justify choice of inflammatory challenge. • Why is there not mention of the viability data? It is interesting to me that cytokine treatment or vibration did not affect cell viability. • IL1B was significantly increased in the inflammatory dynamic condition. Why was this finding not discussed? • The authors state in the current study that no deteriorating effects of vibration were observed on two important ECM components. Were deleterious effects expected? The vibration parameters were not supposed to be traumatic, correct? • In the conclusion, the authors state “Notwithstanding the inherent limitations of an in vivo study, it might suggest that a certain amount of postoperative/-traumatic vocal load might have beneficial impact on wound healing.” First, this is not an in vivo study. Second, are the authors suggesting that traumatic vocal load might have a beneficial impact on wound healing. There is a significant difference between traumatic vocal load and likely restorative vocal fold vibration. I do not feel comfortable or support the statement that traumatic load is good for wound healing. Was the mechanical stimulation in the current study meant to mimic a traumatic load? This statement needs to be clarified. Figure / Figure Captions / Other • In every Figure caption the statistical analysis methods are stated. This is redundant and in the manuscript text. I suggest removing. • Please proofread carefully. Numerous typos and inconsistencies are appreciated throughout the manuscript. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No Reviewer #4: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-19358R1 Exploring the Pathophysiology of Vocal Fold Inflammation: The Molecular Impact of Vibration PLOS ONE Dear Dr. Hortobagyi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please respond to all additional comments from reviewers. Please submit your revised manuscript by Nov 07 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Marie Jetté Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: (No Response) Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes Reviewer #3: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors addressed most of reviewers' comments. However, a few more suggestions are recommended. (1) Abstract: Although IL-1beta is considered a typical inflammatory stimulus, TGF-beta is a pro-fibrotic stimulus. Line 24 will need to revise to reflect better the roles of these two cytokines. (2) Introduction: Some writing edits will be needed. For example. Line 92-99. The transition from introducing Gaston et al and Titze et al' studies and then jumped to Latifi et al.'s bioreactor is abrupt. (3) Introduction. Line 114-115. It is also awkward to mention angiogenic factors in the conclusive statement without reviewing the roles of angiogenic factors in the earlier paragraphs. (4) Methods: Line 205. Suggest to remove the word "novel" because the work is already published. If the authors would like to retain the word, they need to justify further what the novelty of their bioreactor was in the paper. (5) Methods: Line 304. Fix grammatical errors on: "for all other analytes, samples were used undiluted." Also the rationale of not doing validation experiments was weak. As every Luminex plate and experiments may have technical variability, the assumption from previous experiments shall not be applied directly to new experiments. Suggest to run conventional ELISAs for 1-2 markers to confirm the Luminex results. (6) Results: The presentation/ writing will still need to improve. Often times, when reporting certain genes/ proteins have a significant or insignificant change, the authors did not mention the change in relative to which condition/ group. It causes lots of ambiguity in interpreting the results. (7) Discussion. Line 555-561. The discussion on the roles of IL11 remains brief and superficial. Also, the subsequent sentence of discussing mechanical stimulation and anti-inflammatory effects seemed to be irrelevant. The logical flow of the argument herein needs to be strengthened further. (8) Discussion. New studies have revealed the important immunological roles of VF fibroblasts, which should be discussed and cited in the paper. For example: Foote, Al. G., et al. "Tissue specific human fibroblast differential expression based on RNAsequencing analysis." BMC genomics 20.1 (2019): 308. King, S. N., et al. "Vocal fold fibroblasts immunoregulate activated macrophage phenotype." Cytokine 61.1 (2013): 228-236. Li‐Jessen, N. et al. "Cellular source and proinflammatory roles of high‐mobility group box 1 in surgically injured rat vocal folds." The Laryngoscope 127.6 (2017): E193-E200. Reviewer #2: The manuscript has been thoughtfully revised. Please can you address the following: 1) The new title does not address the concern from the previous review that it was too broad and reads like a review. Please revise this to be study specific. e.g. in vitro mechanical vibration down-regulates pro-inflammatory and pro-fibrotic signalling in human vocal fold fibroblasts. 2) Nomenclature: In vivo should be italicized on line 393. Human genes and transcripts should be italicized (line 183, 353, 354, 355, 393, 431, 484, 485, 503, 511, 514, 548). Reword line 490 as nomenclature differs between gene and protein - if you list the full name of the gene/protein this would be fine. 3) Amend line 200 to "After a further 73 hours..." Reviewer #3: Overall, the article is much improved. The increased level of detail helps highlight this unique and important contribution. Grammatical errors have been corrected. I have some minor remaining suggestions: The organization of the Introduction could be improved. Some very short paragraphs were added about the various models; consequently, the revised Introduction does not have good cohesion and flow. I worry that this section seems unfocused: perhaps organization by subheadings would help. For example, Injury/Inflammation Vocal rest (vs. vocalization) Bioreactor systems The statement that therapy “acts primarily as an adjunctive therapy” is not correct with respect to benign lesions [line 55]. Therapy is a primary treatment for nodules and preferred over surgery, for example. The current level of detail in the Method section is welcome. What is the meaning of the “two most prevalent ECM components” of the VF LP being collagen and HA [line 158]? If “most prevalent” means “most abundant”, then this statement is incorrect. HA is often touted as being functionally important; however, it represents less than 1% of the LP (per total tissue protein). Refer PMID: 16514800. The Discussion could use attention to organization and flow also. The authors jump back-and-forth between their findings, some clinical studies, animal studies, a bioreactor study – it is challenging to read and grasp the sequence and logic of the authors’ arguments here. It is especially important to take care because the authors shouldn’t overinterpret their data – which reflect in vitro cell phenotypes under certain conditions (admittedly in a sophisticated experimental set-up) – by implying that they are directly comparable to the results of a clinical vocal rest study, for example. Perhaps subheadings would help here also. The addition of the paragraph on serum starvation is welcome, however it is jarring and seems out-of-place so early in the Discussion. It seems a more natural fit alongside the limitations of the work, later in the Discussion section. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
PONE-D-20-19358R2 In vitro mechanical vibration down-regulates pro-inflammatory and pro-fibrotic signaling in human vocal fold fibroblasts PLOS ONE Dear Dr. Hortobagyi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== Please address Reviewer 2's comments and resubmit. ============================== Please submit your revised manuscript by Dec 04 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Marie Jetté Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: All comments have been well addressed by the authors. The experimental data are also provided in Supplementary Information. Reviewer #2: 1. Italicize uses of latin text. The following sections require correction: Line 479 – italicize in vivo Line 515 – italicize in vitro 2. The authors edited protein symbols (transcripts = cDNA/RNA, not proteins) during the last revision and they now read as genes. Correct nomenclature for human genes and proteins is as follows: Gene/RNA/cDNA - italicize and capitalize gene symbols. You are not required to italicize the gene if you write out the full name. Protein - capitalize protein symbols (no italics) The Hugo Gene Nomenclature Committee website has a full set of gene names/symbols and the guidelines to follow if further clarification is needed. The following sections require correction: Abstract – TGFb, IL1b, aSMA and IL11 are all proteins in this context Line 41 – 48 – Inflammation section refers to proteins Line 171 – 187 – ECM related molecules refers to proteins Line 150 – cytokines are proteins Lines 179 – 189 – all of the enzymes, fibronectin and HA are proteins Lines 200/452/525/571/572/574 - aSMA should reflect protein Line 202 -211 – Should reflect protein Line 286 – 304 - Western blot detects protein Lines 313-314 - Luminex detects protein Line 330 – 332 – ELISA detects protein Line 366-367 – should reflect protein Line 377 – HA is protein in Fig 3a. Line 439 – IL11 and aSMA should reflect protein Line 505 – italicize IL in IL1b Line 514 – Branski paper uses cytokine (protein) IL1b Line 525 – HA and Collagen protein levels measured by ELISA (protein) in Graupp manuscript Lines 536 – 544 – cytokine/ECM components all proteins Line 545 – HA should reflect protein Line 555 – To clarify, in the previous comment addressing line 490 (now 555) I was referring to the convention that by writing a gene name in full, you are not required to italicize it. This allows the term to refer to both gene and protein simultaneously. If you wish to write about changes to gene and protein levels in one sentence, you either have to specify the gene and protein symbols separately, e.g. “FN1 gene and fibronectin protein,” or you could say, “fibronectin gene and protein expression”. My suggestion would be to reword to, “FN1 gene expression and its encoded protein, fibronectin, were upregulated with exposure to cytokines, whereas vibration had no effects.” Line 559 – COX2 should reflect protein Line 579-585 – All of these should reflect protein Line 593 – should reflect proteins Titles in Fig 3,4,5,and 6 - Amend to reflect gene symbols when mRNA expression was measured (proteins are correct) Table 1 (Optional) – consider italicizing gene symbols. When a large number of gene symbols are grouped in a table it is optional to italicize per convention. Reviewer #3: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
In vitro mechanical vibration down-regulates pro-inflammatory and pro-fibrotic signaling in human vocal fold fibroblasts PONE-D-20-19358R3 Dear Dr. Hortobagyi, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Marie Jetté Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-19358R3 In vitro mechanical vibration down-regulates pro-inflammatory and pro-fibrotic signaling in human vocal fold fibroblasts Dear Dr. Hortobagyi: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Marie Jetté Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .